InfuSystem Holdings (INFU) EPS (Basic) Growth (1y) (2011 - 2026)
InfuSystem Holdings (INFU) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 13.85% |
| 10 | InfuSystem Holdings | 244.47 Mn | 243.50 Mn | 21.41 Mn | 30.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.03% |
| Mar 31, 2026 | 583.18% |
| Dec 31, 2025 | 124.68% |
| Sep 30, 2025 | 31.99% |
| Jun 30, 2025 | 280.21% |
| Mar 31, 2025 | 79.87% |
| Dec 31, 2024 | 872.93% |
| Sep 30, 2024 | 145.64% |
| Jun 30, 2024 | 58.32% |
| Mar 31, 2024 | -259.57% |
| Dec 31, 2023 | -31.68% |
| Sep 30, 2023 | 59.35% |
| Jun 30, 2023 | 360.55% |
| Mar 31, 2023 | 10.15% |
| Dec 31, 2022 | -64.56% |
| Sep 30, 2022 | 198.38% |
| Jun 30, 2022 | -119.39% |
| Mar 31, 2022 | -147.75% |
| Dec 31, 2021 | -96.45% |
| Sep 30, 2021 | -114.94% |